Our findings revealed a significant reduction of CaMKKβ in breast cancer cells upon TRPV2 silencing (Fig. 6A-C), while TRPV2 activation with cannabidiol treatment led to increased phosphorylation of CaMKKβ (Fig. 6D-E). This evidence concerns the gene TRPV2 and breast carcinoma.